The drug, developed by Biogen Idec, could achieve sales of billions of dollars a year if the results from the small trial are replicated in larger trials.
from NYT > Home Page http://ift.tt/1OcPoqK
via IFTTT
from NYT > Home Page http://ift.tt/1OcPoqK
via IFTTT